Phase I/II Study of Hydroxychloroquine With Itraconazole With Biochemically Recurrent Prostate Cancer

NCT03513211 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: SUBA-itraconazole
DRUG: Hydroxychloroquine

Sponsor

St Vincent's Hospital, Sydney